Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

Background: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a preparation widely used in chemotherapy for cancers. However, only some patients benefit from this treatment. Therefore, identifying which patients will respond to nab-paclitaxel therapy is crucial. Methods: A cohort of 32 patie...

Full description

Bibliographic Details
Main Authors: Peng Cao, Qilin Zhang, Sanlan Wu, Mitchell A. Sullivan, Yifei Huang, Weijing Gong, Yongning Lv, Xuejia Zhai, Yu Zhang
Format: Article
Language:English
Published: Compuscript Ltd 2023-09-01
Series:Acta Materia Medica
Subjects:
lung cancer
paclitaxel
metabolomics
lipidomics
biomarkers
Online Access:https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0027

Internet

https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0027

Similar Items